|Dietary supplementation of soy germ phytoestrogens or estradiol improves spatial memory performance and increases gene expression of BDNF, TrkB receptor and synaptic factors in ovariectomized rats.|
|Jump to Full Text|
|PMID: 20843342 Owner: NLM Status: PubMed-not-MEDLINE|
|BACKGROUND: Estrogen or phytoestrogens treatment has been suggested to improve cognitive function of the brain in postmenopausal women. However, there is lack of information on the mechanism of such treatment on the central nervous system. The present study aimed to determine the effects of estradiol and soy germ phytoestrogens on spatial memory performance in ovariectomized rats and to explore the underlying mechanisms affecting the central nervous system.
METHODS: Ovariectomized Sprague-Dawley rats were fed a basic diet supplemented with soy germ phytoestrogens (0.4 g/kg or 1.6 g/kg) or 17β-estradiol (0.15 g/kg) for 12 weeks. At the end of the experiment, animals were evaluated for their spatial learning and memory performance by the Morris Water Maze task. The expressions of brain-derived neurotrophic factor (BDNF) and synaptic formation proteins in the hippocampal tissue were estimated using RT-PCR and ELISA.
RESULTS: It was found that rats supplemented with soy germ phytoestrogens or estradiol performed significantly better in spatial memory acquisition and retention when compared to the rats fed on the control diet. Estradiol or the high dose of phytoestrogens treatment significantly increased BDNF concentration and the mRNA levels for BDNF and its TrkB receptors as well as the synaptic formation proteins, synaptophysin, spinophilin, synapsin 1 and PSD-95, in the hippocampal tissue of the experimental animals. It was also found that phytoestrogens, in contrast to estradiol, did not show any significant effect on the vaginal and uteri.
CONCLUSION: Soy germ phytoestrogens, which may be a substitute of estradiol, improved spatial memory performance in ovariectomized rats without significant side-effects on the vaginal and uteri. The memory enhancement effect may relate to the increase in BDNF and the synaptic formation proteins expression in the hippocampus of the brain.
|Meixia Pan; Zhuoneng Li; Victor Yeung; Ruo-Jun Xu|
|Type: Journal Article Date: 2010-09-15|
|Title: Nutrition & metabolism Volume: 7 ISSN: 1743-7075 ISO Abbreviation: Nutr Metab (Lond) Publication Date: 2010|
|Created Date: 2010-10-05 Completed Date: 2011-07-14 Revised Date: 2011-11-21|
Medline Journal Info:
|Nlm Unique ID: 101231644 Medline TA: Nutr Metab (Lond) Country: England|
|Languages: eng Pagination: 75 Citation Subset: -|
|Dept, of Nutrition, Guangdong Academy of Medical Sciences, Guangdong General Hospital, No,106, Zhongshan Er Road, Guangzhou 510080, China. email@example.com.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Nutr Metab (Lond)
Publisher: BioMed Central
Copyright ©2010 Pan et al; licensee BioMed Central Ltd.
Received Day: 7 Month: 7 Year: 2010
Accepted Day: 15 Month: 9 Year: 2010
collection publication date: Year: 2010
Electronic publication date: Day: 15 Month: 9 Year: 2010
Volume: 7First Page: 75 Last Page: 75
Publisher Id: 1743-7075-7-75
PubMed Id: 20843342
|Dietary supplementation of soy germ phytoestrogens or estradiol improves spatial memory performance and increases gene expression of BDNF, TrkB receptor and synaptic factors in ovariectomized rats|
|Meixia Pan13||Email: firstname.lastname@example.org|
|Zhuoneng Li2||Email: email@example.com|
|Victor Yeung3||Email: firstname.lastname@example.org|
|Ruo-Jun Xu3||Email: email@example.com|
1Dept. of Nutrition, Guangdong Academy of Medical Sciences, Guangdong General Hospital, No.106, Zhongshan Er Road, Guangzhou 510080, China
2Food Safety Section, Wuhan Centres for Disease Prevention and Control, No.24 JiangHan Bei Road, Wuhan 430022, China
3School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, China
It has been reported in the literatures that estrogen supplement treatment improves memory acquisition and retention in ovariectomized rats  and postmenopausal women . However, estrogen supplement increases the risk of developing uterine and breast cancer in postmenopausal women . Phytoestrogens supplement has been considered to be a potential alternative treatment without server side effects on the breast and the uterus . Phytoestrogens are a group of compounds with a diphenolic structure similar to that of natural and synthetic estrogens . Phytoestrogens of all chemical groups are widely spread in fruits, vegetables, legumes, whole grains and soy products . It was reported that soy diet rich of phytoestrogens improved working memory in the ovariectomized retired breeder rats . However, there is a lack of understanding in the molecular mechanism of phytoestrogens effects on the brain. Brain-derived neurotrophic factor (BDNF) plays a crucial role in the brain; it regulates the survival, differentiation and phenotypic maintenance of various neuronal populations . It has also been reported that the system of BDNF/tyrosine kinase receptors B (BDNF/TrkB) is expressed in the hippocampus region of the brain and it plays a crucial role in memory acquisition and retention . BDNF improves the survival of hippocampal neurons and restores hippocampal neurogenesis [10,11]. Our preliminary study showed that estradiol and phytoestrogens, genestein and daidzein increased BDNF expression in fetal rat hippocampal neurons in vitro (data not shown). Thus, we suspect that the action of phytoestrogens or estradiol on the central nervous system, particularly on its learning and memory function, may be mediated by BDNF expression. The objective of the present study was to examine the effects of dietary supplementation of estradiol or phytoestrogens on the spatial reference memory behavior in overiectomized rats and its relation to BDNF and TrkB receptor expression in the hippocampal region of the brain. As synaptic formation in the hippocampus plays an important role in learning and memory function of the brain , the effects of dietary supplementation of estradiol or phytoestrogens on hippocampal gene expression of various synaptic formation proteins were also examined.
The experimental protocol was approved by the animal ethic committee of the University of Hong Kong (approval code: 1072-05). Twenty-eight female Sprague-Dawley rats aged 3 months were obtained from the Laboratory Animal Unit of the University of Hong Kong. All animals received a surgical operation to remove both ovaries under general anaesthesia of intraperitoneal injection of ketamine (60 mg/kg, Sigma, USA) and xylazine (10 mg/kg, Sigma, USA). After eighteen days of recovery, the ovariectomized rats were randomly segregated into four treatment groups (n = 7). Animals in one group were maintained on the control diet (Table 1) for 12 weeks. Animals in the remaining three groups were maintained on the control diet supplemented with 0.15 g/kg 17β-estradiol, or supplemented with 0.4 g/kg or 1.6 g/kg soy germ phytoestrogens respectively. The phytoestrogens was a soy germ product (SoyLife 40%, ACATRIS, Netherlands, Batch No. 01 M/1910/4), containing 152 mg/g daidzein, 80 mg/g glycitein and 35 mg/g genistein.
At the end of the feeding experiment all animals were evaluated for their spatial memory performance by Morris Water Maze (MWM) test. The swimming pool used for the test was 190 cm in diameter and 60 cm deep. The escape platform (100 cm2) was fixed in a permanent position 2 cm under the water surface during the course of the MWM training procedure. The quadrant housing the escape platform was defined as the target zone. The water in the pool was made opaque with coffee-mate powder to prevent the rats from seeing the platform, and the temperature of the water was maintained at 22-25°C. Spatial reference cues (arrow, star, circle, and rectangle) around the pool were remained constant during the test. For spatial learning acquisition test, the rats were trained in MWM for 5 consecutive days using 3-trial-per-day regime. The rats were placed into the pool facing the wall randomly from one of the three starting points located in the three quadrants except the quadrant with the platform. If the animals failed to find the platform by the maximum period of 120 seconds, they would be gently placed on the platform. At the end of each trial, the rats were allowed to rest on the platform for 30 s. The time (escape latency) and swimming distance to reach the platform were recorded by a video camera and analyzed using the computer software (Noldus). To assess spatial memory retention, a probe trial was performed 1 day after the last training trial, during which the platform was removed from the pool, while all other factors remained unchanged. Rats were allowed to swim for 90 s.
Estrous status was observed using vaginal smear performed for 10 consecutive days from the first day of the 11th week of the feeding experiment. Vaginal smears were obtained by flushing the rats' vagina with 0.2 ml 0.9% saline with a blunt-end tip. The resulting suspension was placed on a slide, covered with a cover slip and examined with a microscope.
After completion of the spatial memory tests, the animals were euthanized. The brains were rapidly removed and placed on ice. The hippocampus were then isolated, frozen in liquid nitrogen and stored at -80°C.
The uterus of each animal was removed and weighted, and then fixed in 10% buffered formalin for 48 h. The right side of the proximal region of each uterus was embedded in paraffin wax, and 5 μm cross tissue sections were stained with hematoxylin and eosin (H&E) for histological evaluation.
The extraction of BDNF from the hippocampal tissue was performed on ice and following the description of Szapacs . In brief, the tissue was suspended in 5 volume of lysis buffer containing 137 mM NaCl, 20 mM Tris-HCl, 1% NP40, 10% glycerol, 1 mM PMSF, 0.5 mM sodium vanadate and protein inhibitor cocktail (Calbiochem, USA). The suspension was homogenized on ice for 20 s using a sonicater at power level 3 and pulses at 1 s. The homogenates were then centrifuged at 16000×g for 30 min at 4°C. The resulting supernatant was stored at -80°C for further analyses.
Mature BDNF was measured using a sensitive two-side ELISA kit (BDNF-Emax ImmunoAssay system, Promega) following the manufacturer's instructions. In brief, 96-well ELISA plates were coated with 100 μl/well of anti-BDNF monoclonal antibody and incubated overnight at 4°C. Following wash with the washing buffer containing 0.05% (v/v) Tween 20, 20 mM Tris-HCl, and 150 mM NaCl, pH 7.6, the plate was incubated for 1 h with 200 μl/well of block & sample buffer to prevent non-specific binding. The plate was washed again and 100 μl/well of samples or standard (0-500 pg rhBDNF/ml) was added to the plate in duplicates followed by incubation with shaking for 2 h. After washing, 100 μl/well of anti-human BDNF antibody (1 μg/ml) was added followed by 2 h incubation with shaking. After washing again, 100 μl/well of Anti-IgY HRP was added followed by 1 h incubation with shaking. After the last washing, 100 μl/well of tetramethylbenzidine solution was added followed by 10 min incubation with shaking. The enzymatic reaction was stopped by addition of 100 μl/well of 1N HCl. The absorbance of the reaction product was measured within 30 min at 450 nm using a micro-plate reader. The concentration of BDNF in the samples was calculated from the rhBDNF standard curve by linear regression analysis performed on each micro-plate, and the BDNF were expressed as pg of BDNF per mg protein. The total BDNF in the sample was measured after the transient acidification treatment of the sample below pH3.
Reverse transcription polymerase chain reaction (RT-PCR) was used to evaluate the mRNA levels for BDNF (NM012513), TrkB (NM012731), synaptotagmin 1 (NM001033680), synaptophysin (NM012664), synapsin 1 (X04655), PSD-95 (N96853) and spinophilin (AF016252). The mRNA for GADPH (NM017008) was used as an internal control. Primers specific to target genes were designed from public sequences using Primer 3 software http://fokker.wi.mit.edu/primer3/input.htm. Sequences of PCR primers were shown in Table 2.
Total RNA was extracted using AllPrep™ DNA/RNA/Protein Mini Kit (Qiagen, USA). The concentration and purity of RNA were measured by the optical density at 260 and 280 nm using spectrophotometer (Bio-Rad). Reverse transcription (RT) reactions were performed in duplicates with SuperScript™ III First-strand Synthesis SuperMix (Invitragen, USA). PCR was performed with 1 μl of cDNA in 25 μl reaction mixture containing 2.5 μl of 10× AccuPrimer™ PCR Buffer II, 0.5 μl primer mix (10 μM each), 0.5 μl AccuPrimer™ Taq DNA Polymerase (Invitrogen, cat.No.12339-016, USA). The conditions of PCR amplification of cDNA were shown in Table 2. Finally, 5 μl of the PCR products was resolved by 1% agarose gel electrophoresis, stained with SYBR® Safe DNA gel stain (Invitrogen, USA) and visualized under UV light. The density of the PCR products was analyzed by Quantity One software (Bio-Rad, USA). Quantity of the expressed BDNF mRNA was analyzed based on a gray value, and expressed as the ratio of the sample density to GAPDH density amplified from an identical RNA sample.
Data are presented as the mean ± standard error of the mean (SEM). All data were evaluated for equality of variance before statistical analysis. Statistical analysis of experimental data was carried out using software SPSS v15.0 (USA). Statistical differences were determined by one-way or two-way ANOVA followed by Student-Newman-Keuls post hoc test. Differences were considered significant when p < 0.05.
There was no difference in the initial body weights among the four groups of animals. During the experimental period, rats in the control group and those in the group supplemented with low dose of phytoestrogens gained body weight steadily and followed the similar growth pattern. Rats in the group supplemented with high dose of soy germ phytoestrogens gained much less weight, while rat in the group supplemented with estradiol gained nearly no weight during the experimental period. By the end of the feeding experiment rats in the control group and in the groups supplemented with low dose of phytoestrogens, or high dose of phytoestrogens or estradiol treatment gained (96.28 ± 13.63)g, (89.15 ± 11.9)g, (48.67 ± 14.13)g and (2.10 ± 11.38)g of body weight, respectively.
The average weight of the uteri from the rats treated with estradiol was (0.56 ± 0.04)g, which was significantly greater than the weight from the control animals ((0.10 ± 0.01)g, p < 0.05). The average uterus weights of rats received the low or high dose of phytoestrogens treatment were (0.12 ± 0.01)g and (0.14 ± 0.01)g respectively, and they did not significantly differ from that of the controls.
Representative vaginal smears of experimental animals were shown in Figure 1. The smear examination for the consecutive 10 days showed no estrus cycle in rats on the control diet or on the diet supplemented with low or high dose of phytoestrogens. The vaginal smear of these animals showed mainly leukocytes and a few irregularly shaped cornified epithelial cells. In contrast, the smear from the animals supplemented with estradiol showed preponderance of large, irregularly noncornified epithelial cells.
The uterine histological characteristics of experimental animals were shown in Figure 2. In the control rats, the uterus appeared atrophic. The endometrium was composed of cuboidal inactive cells, and the connective tissue showed unorganized round nuclei. No mitotic activity was detected in epithelial cells. Similar morphologic characteristics were observed in the uterus of rats receiving low dose of phytoestrogens. In rats receiving high dose of phytoestrogens, endometrial cells of the uterus were stimulated but no pathologic signs were detected. However, in rats receiving estradiol treatment, endometrial mitotic activity was found, and all uterine structures were hypertrophic and hyperplastic.
To assess spatial learning acquisition, animals were trained with 3 trials per day for 5 consecutive days on the MWM task. The differences in escape latency (time to find the platform) and swimming distance of each training day among the four treatment groups were analyzed by two-way repeated measures ANOVA. On the first day of training, no difference was found in escape latency among the four groups. The escape latency gradually declined over the training period for all groups (Figure 3), indicating a gradual spatial memory acquisition in all experimental animals. Statistical analysis of two-way ANOVA (4 groups × 5 days) with repeated measures showed significant differences between the days of training (F = 40.47, p < 0.001) and among the treatment groups (F = 5.329, p = 0.002). There was also a significant interaction between the days of training and the treatments (F = 2.558, p = 0.046). On the 5th day of training the escape latency of rats received the high dose of phytoestrogens or estradiol treatment was significantly shorter than that of the controls (p < 0.05, Figure 3).
A similar trend was observed in the swimming distance taken by rats to locate the platform. The distance reduced gradually for all animals over the training period (Figure 3). Statistical analysis of two-way ANOVA (4 groups × 5 days) with repeated measures showed significant differences between the days of training (F = 45.942, p < 0.001), and among the treatment groups (F = 3.008, p = 0.036) with a significant interaction between the training time and the treatment (F = 3.063, p = 0.034). On the 5th day of training the swimming distance of rats received the high dose of phytoestrogens or estradiol treatment was significantly shorter than that of the controls (p < 0.05, Figure 3).
There was no significantly difference in the swimming speed among the treatment groups at the end of 5 day training (Figure 3). Statistical analysis showed that the swimming speed was negatively correlated with the body weight gains during the 12 weeks of feeding experiment (r = -0.230, p < 0.001).
The results of the probe tests are presented in Figure 4. All animals showed a trend of spending more time in the target quadrant of the swimming pool. For animals received phytoestrogens or estradiol treatment, the relative time spent and distance travelled in the target quadrant were significantly greater than those in other quadrants (p < 0.05).
In the hippocampal tissue, BDNF was detected by a specific ELISA assay. The levels of both total BDNF and its mature form were significantly higher in animals received phytoestrogens or estradiol treatment when compared with that in control animals (F = 5.162, p < 0.05; F = 10.551, p < 0.05; Figure 5). The mature BDNF contributed about 20-22% of the total BDNF, and there was no significant difference among the four treatment groups in the conversion of pro-BDNF to mature BDNF.
In accordance with the significant effects on BDNF levels, phytoestrogens or estradiol treatment increased BDNF gene expression (Figure 6). Compared with that of control animals, the BDNF mRNA level was significantly greater in the hippocampal tissue of the animals treated with estradiol or high dose of soy germ phytoestrogens (F = 3.469, p < 0.05). The level of BDNF mRNA was greater in the hippocampal tissue of the animals received low dose of phytoestrogens, although not significant, than that of control animals (Figure 6).
The mRNA level of TrkB, the primary receptor of BDNF, was also significantly greater in the hippocampal tissue of animals received estradiol or high dose of phytoestrogens treatment compared with that of the control animals (F = 3.244, p < 0.05).
Synaptic formation plays an important role in learning and memory function of the brain. Figure 7 presents the relative expression levels of genes of various proteins related to synaptic formation in the hippocampal tissue of the experimental animals. The data showed that the mRNA levels of synaptophysin, synapsin 1 and spinophilin were significantly increased in rats received estradiol or high dose of soy germ phytoestrogens treatment when compared with that of the control animals (F = 3.557, p < 0.05; F = 3.453, p < 0.05; F = 3.363, p < 0.05). The mRNA level of PSD-95 was significantly increased in rats received estradiol treatment compared with that of the control animals (F = 3.284, p < 0.05). No difference in mRNA level of synaptotagmin 1 was observed among the treatment groups.
It has been reported that estrogen replacement therapy improves learning and memory function of the brain in ovariectomized aged rats  and postmenopause women . However, estrogen treatment often has severe side effects and may increases the risk of uterine or breast cancer . There have been wide interests in searching for alternative compounds, and phytoestrogens have been considered as potential candidates.
To evaluate the effect of estradiol and soy germ phytoestrogens on memory function, the spatial learning acquisition and memory retention of rats were tested using the Morris water maze (MWM) . This task is based upon the premise that animals have evolved an optimal strategy to explore their environment and escape from the water with a minimum amount of effort, i.e., swimming the shortest distance possible. For spatial learning acquisition test, the time (escape latency) and swimming distance to reach the platform were recorded for each rat. To assess spatial memory retention, a probe trial was performed, during which the platform was removed from the pool, and the percentage of time spent in each quadrant was calculated and their swim paths were recorded by a video tracking system. The present study demonstrated that soy germ phytoestrogens, as well as estradiol, improved spatial learning and memory in ovariectomized rats. It was observed that, when compared to the animals fed on the control diet, rats fed on the diet supplemented with 1.6 g/kg soy germ phytoestrogens or 0.15 g/kg estradiol spent significantly shorter time to find the hidden platform (escape latency) during the Morris water maze training. Although the reduction in escape latency may partially result from the improved swimming speed, the same animals took significant shorter swimming distance to find the hidden platform than did the control animals (Figure 3). It was further showed that ovariectomized rats received the phytoestrogens or estradiol treatment had stronger spatial bias in the probe test than the controls (Figure 4). These findings suggest that dietary supplementation of phytoestrogens or estradiol improved memory acquisition and retention in ovariectomized rats. Similar findings have also been reported in the literature. Xu et al  reported that estradiol or genistein treatment given by subcutaneous injection reduced the escape latency of ovariectomized rats in a behavioral test. Estradiol or soy phytoestrogens treatment enhanced hippocampal-dependent spatial working memory in female mice  and ovariectomized retired breeder rats . In postmenopausal women, dietary supplementation of soya isoflavones for 12 weeks significantly improved cognitive functions of the brain including learning rule reversals and planning task .
In contrast to the estradiol treatment, dietary supplementation of phytoestrogens showed no significant effect on the vaginal and uteri. Vaginal smear showed an estrus status in animals treated with estradiol but not in animals treated with control diet or phytoestrogens (Figure 1). We also found that estradiol, but not phytoestrogens, significantly increased the weight of uterus and stimulated cell proliferation in the uterus endometrium (Figure 2). Our data was supported by the report that daily treatment of genistein at 500 mg/kg(body weight) had no estrogenic effect in the uterus or the mammary gland in rats . These findings indicate that dietary supplementation with phytoestrogens may have the benefit of improving cognitive function of the brain but without the severe side effect on the reproductive tract.
Although the findings of the present study and various earlier reports indicated that phytoestrogens or estradiol treatment has a beneficial effect on the brain cognitive function, how these compounds act on the brain is not clear. Consistent with Simpkins'  and Pan's  reports, we found that estradiol or phytoestrogens treatment significantly increased the levels of BDNF, especially mature BDNF, in the hippocampus, the known learning and memory centre of the brain. It was further showed that estradiol or phytoestrogens treatment significantly increased the mRNA levels for BDNF and its receptor TrkB in the hippocampus (Figure 6). BDNF is a member of the neurotrophin gene family which plays a crucial role in survival, differentiation, phenotypic maintenance, and in the selective vulnerability of various neuronal populations within the normal and diseased brain . The postsynaptic BDNF-TrkB pathway is crucial for regulation of excitatory synaptic transmission and long-term potentiation (LTP) induction, which is an important synaptic connection model of memory formation . This property implicates BDNF in the process of learning and memory [22,23]. Moreover, neurotrophins initially synthesized as precursors (proneurotrophins), they are cleaved to produce mature proteins, which promote neuronal survival and enhance synaptic plasticity by activating Trk receptor tyrosine kinases. Recent studies indicate that proneurotrophins serve as signalling molecules by interacting with the p75 neurotrophin receptor (p75NTR) which often has biological effects that oppose those of mature neurotrophins. Therefore, the proteolytic cleavage of proneurotrophins represents a mechanism that controls the direction of action of neurotrophins. Although Murphy et al  found estrogen treatment temporally reduced BDNF in hippocampal cultures within 24 h of exposure, estrogen and/or phytoestrogens finally increased BDNF expression after certain period of culture. Indeed, it has been evidenced that estradiol regulated neurotrophins expression including BDNF [20,26-30]. Our study indicated that to observe the effect of phytoestrogens treatment, an effective period should be consider in the studies of both in vivo and in vitro. On the other hand, phytoestrogens might show different performance in vivo base on the gonadal hormones states. For the female, especially the peri-menopause with estrogen reducing, phytoestrogens will play a beneficial or substitute effect.
Synaptic formation plays an important role in the cognitive function of the brain. Synaptic loss is considered to be a reliable index of impaired cognition in dementia . The present study demonstrated that estradiol or phytoestrogens treatment significantly increased the expression of genes of various proteins related to synaptic formation in the hippocampus. Dietary supplement of 0.15 g/kg estradiol or 1.6 g/kg phytoestrogens significantly increased the mRNA levels of synaptophysin, synapsin 1, PSD-95 and spinophilin in the hippocampus tissue (Figure 7). Synaptophysin, synaptotagmin 1 and synapsin 1 are belong to the presynaptic vesicle proteins which play an important role in synaptic plasticity and cognitive function . Loss of the synaptophysin in hippocampus correlates with cognitive decline in Alzheimer's disease . PSD-95 and spinophilin belongs to postsynaptic proteins involved in synapse stabilization and plasticity . It is suspected that increased expression of genes of synaptic proteins may be partially responsible for the improved learning and memory performance following dietary supplementation of estradiol or phytestrogens in ovariectomized rats.
In summary, the present study showed that phytoestrogens or estradiol treatment improved spatial memory acquisition and retention in ovariectomized rats. Unlike estradiol, phytoestrogens had no significant effect on the reproductive system. These finding suggest that phytoestrogens may be used in postmenopause women to improve cognitive function of the brain without the severe risk of developing uterus or breast cancer. The present study further showed that the increased gene expression for BDNF and its receptor TrkB and for various proteins related to synaptic formation in the hippocampus may be partially responsible for the improved spatial learning and memory performance in ovariectomized rats following dietary supplementation of estradiol or phytoestrogens.
BDNF: brain-derived neurotrophic factor; p75NTR: p75 neurotrophin receptor; MWM: Morris water maze; TrkB: tyrosine kinase receptors B; LTP: long-term potentiation; PSD-95: postsynaptic density protein 95.
The authors declare that they have no competing interests.
MP participated in the design of the study, animal feeding, behaviours testing, and sample collection, gene and protein expression measurements, statistical analysis and drafting of the paper. ZL participated in the animal feeding, behaviours testing and sample collection. VY participated in the perform behaviours testing and management of molecular studies. RJX conceived the study, and participated in its design, interpretation and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
The authors thank Dr. Marian A. Verbruggen from Acatris Specialities Holding B.V. (The Netherlands) for providing the products soy germ phytoestrogens (SoyLife 40) used in present study. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. The authors also express thanks to Dr. Meizi He for her important intellectual comment.
|Gibbs RB,Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged ratsNeurobiol AgingYear: 20002110711610.1016/S0197-4580(00)00103-210794855|
|Resnick SM,Metter EJ,Zonderman AB,Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?NeurologyYear: 199749149114979409335|
|Hammond CB,Women's concerns with hormone replacement therapy--compliance issuesFertil SterilYear: 199462157S160S7958011|
|Messina M,Barnes S,Setchell KD,Phyto-oestrogens and breast cancerLancetYear: 199735097197210.1016/S0140-6736(05)64062-79329507|
|Miksicek RJ,Estrogenic flavonoids: structural requirements for biological activityProc Soc Exp Biol MedYear: 199520844507892294|
|Patisaul HB,Phytoestrogen action in the adult and developing brainJ NeuroendocrinolYear: 200517576410.1111/j.1365-2826.2005.01268.x15720476|
|Pan Y,Anthony M,Clarkson TB,Evidence for up-regulation of brain-derived neurotrophic factor mRNA by soy phytoestrogens in the frontal cortex of retired breeder female ratsNeurosci LettYear: 1999261172010.1016/S0304-3940(98)00994-X10081916|
|Barde YA,Edgar D,Thoenen H,Purification of a new neurotrophic factor from mammalian brainEMBO JYear: 198215495537188352|
|Murer MG,Yan Q,Raisman-Vozari R,Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's diseaseProg NeurobiolYear: 2001637112410.1016/S0301-0082(00)00014-911040419|
|Duman RS,Heninger GR,Nestler EJ,A molecular and cellular theory of depressionArch Gen PsychiatryYear: 1997545976069236543|
|Malberg JE,Eisch AJ,Nestler EJ,Duman RS,Chronic antidepressant treatment increases neurogenesis in adult rat hippocampusJ NeurosciYear: 2000209104911011124987|
|Liao D,Jones A,Malinow R,Direct measurement of quantal changes underlying long-term potentiation in CA1 hippocampusNeuronYear: 199291089109710.1016/0896-6273(92)90068-O1334418|
|Szapacs ME,Mathews TA,Tessarollo L,Ernest Lyons W,Mamounas LA,Andrews AM,Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expressionJ Neurosci MethodsYear: 20041401-2819210.1016/j.jneumeth.2004.03.02615589338|
|Wenk GL,Current Protocols in Neuroscience. copyright@2003Year: 2004John Wiley & Sons, Inc 8.5.A.5.|
|Xu J,Zhu J,Shi C,Guo K,Yew DT,Effects of genistein on hippocampal neurodegeneration of ovariectomized ratsJ Mol NeurosciYear: 20073110111210.1007/s12031-007-0010-y17478884|
|Li C,Brake WG,Romeo RD,Dunlop JC,Gordon M,Buzescu R,Magarinos AM,Allen PB,Greengard P,Luine V,McEwen BS,Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female miceProc Natl Acad Sci USAYear: 20041012185219010.1073/pnas.030731310114766964|
|Clarkson TB,Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy?MenopauseYear: 20007717510.1097/00042192-200007020-0000210746888|
|Duffy R,Wiseman H,File SE,Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavonesPharmacol Biochem BehavYear: 20037572172910.1016/S0091-3057(03)00116-312895690|
|Michael McClain R,Wolz E,Davidovich A,Pfannkuch F,Edwards JA,Bausch J,Acute, subchronic and chronic safety studies with genistein in ratsFood Chem ToxicolYear: 200644568010.1016/j.fct.2005.05.02116213646|
|Simpkins JW,Singh M,Bishop J,The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's diseaseNeurobiol AgingYear: 199415Suppl 2S19519710.1016/0197-4580(94)90205-47700453|
|Kovalchuk Y,Hanse E,Kafitz KW,Konnerth A,Postsynaptic Induction of BDNF-Mediated Long-Term PotentiationScienceYear: 20022951729173410.1126/science.106776611872844|
|Altar CA,DiStefano PS,Neurotrophin trafficking by anterograde transportTrends NeurosciYear: 19982143343710.1016/S0166-2236(98)01273-99786341|
|Connor B,Dragunow M,The role of neuronal growth factors in neurodegenerative disorders of the human brainBrain Res Brain Res RevYear: 19982713910.1016/S0165-0173(98)00004-69639663|
|Lu B,Pang PT,Woo NH,The yin and yang of neurotrophin actionNat Rev NeurosciYear: 2005660361410.1038/nrn172616062169|
|Murphy DD,Cole NB,Segal M,Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neuronsProc Natl Acad Sci USAYear: 199895114121141710.1073/pnas.95.19.114129736750|
|Berchtold NC,Kesslak JP,Pike CJ,Adlard PA,Cotman CW,Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampusEur J NeurosciYear: 2001141992200210.1046/j.0953-816x.2001.01825.x11860494|
|Miranda RC,Sohrabji F,Toran-Allerand D,Interactions of estrogen with the neurotrophins and their receptors during neural developmentHorm BehavYear: 19942836737510.1006/hbeh.1994.10337729805|
|Sohrabji F,Miranda RC,Toran-Allerand CD,Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factorProc Natl Acad Sci USAYear: 199592111101111410.1073/pnas.92.24.111107479947|
|Solum DT,Handa RJ,Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampusJ NeurosciYear: 2002222650265911923430|
|Toran-Allerand CD,Singh M,Setalo G Jr,Novel mechanisms of estrogen action in the brain: new players in an old storyFront NeuroendocrinolYear: 1999209712110.1006/frne.1999.017710328986|
|DeKosky ST,Scheff SW,Styren SD,Structural correlates of cognition in dementia: quantification and assessment of synapse changeNeurodegenerationYear: 1996541742110.1006/neur.1996.00569117556|
|Sze CI,Bi H,Kleinschmidt-DeMasters BK,Filley CM,Martin LJ,Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brainsJ Neurol SciYear: 2000175819010.1016/S0022-510X(00)00285-910831767|
|Sze CI,Troncoso JC,Kawas C,Mouton P,Price DL,Martin LJ,Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer diseaseJ Neuropathol Exp NeurolYear: 19975693394410.1097/00005072-199708000-000119258263|
|El-Husseini AE,Schnell E,Chetkovich DM,Nicoll RA,Bredt DS,PSD-95 involvement in maturation of excitatory synapsesScienceYear: 20002901364136811082065|
The composition of the control diet based on the formula of AIN-93G purified diet.
Sequences of PCR primers and conditions of PCR amplification of cDNA.
|Conditions of PCR amplification of cDNA|
|Primer name||Sequences||Products (bps)||Tm||length||OD's||Denaturation||Annealing||Extension||Cycles|
|GAPDH forward||gggtgtgaaccacgagaaat||481||47||20||11||94°C for 30 s||55°C for 30 s||68°C for 35 s||33|
|BDNF forward||tgtgacagtattagcgagtgggt||219||59.1||23||5||94°C for 30 s||50°C for 30 s||68°C for 15 s||40|
|TrkB forward||cttatgcttgctggtcttgg||503||47||20||10.4||94°C for 30 s||59°C for 60 s||72°C for 35 s||38|
|Synaptophysin forward||catcttcgcctttgctacg||508||46||19||10.8||94°C for 30 s||55°C for 30 s||68°C for 35 s||40|
|synaptotagmin 1 forward||gttgcggtccttttagtcgt||496||47||20||9.3||94°C for 30 s||55°C for 30 s||68°C for 35 s||33|
|synaptotagmin 1 reverse||agtcatacacagccatcacca||47||21||9.6|
|synapsin 1 forward||agcagcacaacataccctgtag||459||50||22||12.3||94°C for 30 s||52°C for 30 s||68°C for 35 s||40|
|synapsin 1 reverse||gaccacaagttccacgatga||47||20||7.7|
|PSD-95 forward||gccctgtttgattacgaca||492||44||19||8.2||94°C for 30 s||55°C for 30 s||68°C for 35 s||40|
|spinophilin forward||gaggaaagtggggagtctga||510||48||20||8.2||94°C for 30 s||58°C for 30 s||72°C for 35 s||37|
Previous Document: Left ventricular noncompaction and myocardial fibrosis: a case report.
Next Document: Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast diff...